AROS – the company and staff
AROS provides service to industry and universities world-wide. The service
includes sample banking, extraction of molecules, microarray analysis,
PCR-based testing, and large clinical cohort studies.
AROS develops and test new molecular diagnostic technologies both
in vitro and based on clinical materials.
The Dept. of Clinical Biochemistry at the University Hospital purchased
the first academic Affymetrix system in Europe in 1999, and quickly became
a reference laboratory for Affymetrix in Europe. As service for the Pharma
industry grew rapidly, it was decided to spin-out AROS as an independent
company.
AROS was established as a private
limited company (Ltd)
in the year 2000 by three researchers from Aarhus University Hospital
, the Hospital, and a local public investment fund.
AROS moved to its own facility, expanded, and - in 2005 - had to
move to a new larger facility in a new Biomedical Research park, located
next to the University Hospital.
AROS transformed into an incorporated company (Inc.) in 2005 and has had a positive balance since 2002.
• AROS is headed by professor Torben F. Ørntoft (CEO)
• production
and management is the responsibility of PhD Thomas
Thykjaer (CMO)
• research and development is the responsibility of PhD Mogens
Kruhøffer (CSO)
The staff
AROS has been steadily growing and has kept
the position as the leading service provider for Affymetrix in Europe.
Up to date, AROS staff has hybridized and analysed more than 12,000 microarrays.
The staff has carefully been selected for technological skills, as well
as talent for quality assured performance. On top of that the staff is
friendly and always interacting with the customers according to their
needs.
AROS has:
• Academic staff (all PhD´s) with a long track record in microarray
and molecular research
• Quality assurance staff trained at European level
• Technicians with many years of experience in microarray handling
• Support staff taking care of shipments, contracts, array purchase etc.